Critical Contrast: CVR Medical (OTCMKTS:CRRVF) and Azenta (NASDAQ:AZTA)

Azenta (NASDAQ:AZTA) and CVR Medical (OTCMKTS:CRRVF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Insider and Institutional Ownership

99.1% of Azenta shares are held by institutional investors. 10.9% of Azenta shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Azenta and CVR Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Azenta	$596.48 million	1.56	-$55.76 million	($3.96)	-5.10
CVR Medical	N/A	N/A	N/A	($0.02)	N/A

CVR Medical has lower revenue, but higher earnings than Azenta. Azenta is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Azenta and CVR Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Azenta	1	3	4	0	2.38
CVR Medical	0	0	0	0	0.00

Azenta currently has a consensus price target of $39.50, suggesting a potential upside of 95.74%. Given Azenta’s stronger consensus rating and higher probable upside, equities analysts clearly believe Azenta is more favorable than CVR Medical.

Profitability

This table compares Azenta and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Azenta	-30.49%	1.23%	1.02%
CVR Medical	N/A	N/A	N/A

Volatility & Risk

Azenta has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, CVR Medical has a beta of 32.6, suggesting that its share price is 3,160% more volatile than the S&P 500.

Summary

Azenta beats CVR Medical on 8 of the 11 factors compared between the two stocks.

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.